Home › NDC Lookup › RxCUI directory › RxCUI 1250282

Aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Acid Gone] — RxCUI 1250282

RxNorm drug concept · Semantic branded drug
RxCUI 1250282 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1250282
Official nameAluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Acid Gone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAcid Gone Extra Strength (aluminum hydroxide 160 MG / magnesium carbonate 105 MG) Chewable Tablet; Acid Gone Extra Strength 160 MG / 105 MG Chewable Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)953 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aluminum Hydroxide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The oral liquid is an antacid — you take it by mouth to relieve heartburn, acid indigestion, and sour stomach. ProCure DryDrox is a completely different...
  • What is aluminum hydroxide actually used for?
  • Give the bottle a good shake before every use — that's important. Take 2 teaspoonfuls up to 5 to 6 times a day, after meals and at bedtime, followed by a small sip of water if you...
  • How do I take the oral liquid correctly?
📖 Read our full Aluminum Hydroxide guide →

🕸️ Concept Web — How Aluminum hydroxide 160 MG / magnesium carbonate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Acid Gone] RxCUI 1250282

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Aluminum hydroxide 612
    • Magnesium carbonate 29155
    • Aluminum hydroxide / magnesium carbonate 1029441
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Acid Gone 352396
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aluminum hydroxide / magnesium carbonate Chewable Tablet 370831
    • Aluminum hydroxide / magnesium carbonate Chewable Product 1295366
    • Aluminum hydroxide / magnesium carbonate Oral Product 1155940
    • Aluminum hydroxide / magnesium carbonate Pill 1155941
    • Aluminum hydroxide / magnesium carbonate Chewable Tablet [Acid Gone] 1250279
    • Acid Gone Chewable Product 1296245
    • Acid Gone Oral Product 1168431
    • Acid Gone Pill 1250281
    • +4 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet SCD · 308072
  • Aluminum hydroxide 160 MG SCDC · 315328
  • Magnesium carbonate 105 MG SCDC · 317410
  • Aluminum hydroxide / magnesium carbonate Chewable Tablet SCDF · 370831
  • Aluminum hydroxide / magnesium carbonate Chewable Product SCDG · 1295366
  • Aluminum hydroxide / magnesium carbonate Oral Product SCDG · 1155940
  • Aluminum hydroxide / magnesium carbonate Pill SCDG · 1155941

Brand-Name Concepts

  • Aluminum hydroxide 160 MG / magnesium carbonate 105 MG [Acid Gone] SBDC · 1250278
  • Aluminum hydroxide / magnesium carbonate Chewable Tablet [Acid Gone] SBDF · 1250279
  • Acid Gone Chewable Product SBDG · 1296245
  • Acid Gone Oral Product SBDG · 1168431
  • Acid Gone Pill SBDG · 1250281
  • Acid Gone BN · 352396

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1250282 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-5365-60 100 TABLET, CHEWABLE in 1 BOTTLE (0904-5365-60) Acid Gone Antacid Extra Strength Major Pharmaceuticals 2014-06-06
Observed labelers: Major Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0462
Range $0.0462–$0.0462 · middle 50% $0.0462–$0.0462 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.